VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,759,623 | -14.0% | 65,389 | -3.8% | 0.03% | -13.3% |
| Q2 2023 | $2,046,216 | -8.0% | 67,958 | -1.2% | 0.03% | -14.3% |
| Q1 2023 | $2,224,322 | +16.3% | 68,758 | +3.1% | 0.04% | +9.4% |
| Q4 2022 | $1,911,985 | +11.8% | 66,713 | -5.9% | 0.03% | 0.0% |
| Q3 2022 | $1,710,000 | -19.1% | 70,915 | -8.2% | 0.03% | -20.0% |
| Q2 2022 | $2,115,000 | -27.8% | 77,253 | +1.1% | 0.04% | -18.4% |
| Q1 2022 | $2,929,000 | +8.1% | 76,387 | -9.7% | 0.05% | +11.4% |
| Q4 2021 | $2,709,000 | +14.3% | 84,569 | +5.2% | 0.04% | -4.3% |
| Q3 2021 | $2,370,000 | +200.4% | 80,405 | +246.3% | 0.05% | +187.5% |
| Q2 2021 | $789,000 | +4.6% | 23,215 | 0.0% | 0.02% | -5.9% |
| Q1 2021 | $754,000 | +2.2% | 23,215 | +13.3% | 0.02% | -5.6% |
| Q4 2020 | $738,000 | -8.0% | 20,483 | 0.0% | 0.02% | -21.7% |
| Q3 2020 | $802,000 | -41.7% | 20,483 | -45.4% | 0.02% | -46.5% |
| Q2 2020 | $1,376,000 | +59.3% | 37,501 | 0.0% | 0.04% | +22.9% |
| Q1 2020 | $864,000 | -36.2% | 37,501 | -18.9% | 0.04% | -20.5% |
| Q4 2019 | $1,354,000 | +9.6% | 46,248 | 0.0% | 0.04% | -20.0% |
| Q3 2019 | $1,235,000 | +4.5% | 46,248 | 0.0% | 0.06% | +3.8% |
| Q2 2019 | $1,182,000 | +14.0% | 46,248 | 0.0% | 0.05% | 0.0% |
| Q1 2019 | $1,037,000 | +6.4% | 46,248 | 0.0% | 0.05% | -7.0% |
| Q4 2018 | $975,000 | -57.6% | 46,248 | -62.7% | 0.06% | -51.3% |
| Q3 2018 | $2,298,000 | -16.7% | 124,094 | +0.4% | 0.12% | -21.5% |
| Q2 2018 | $2,758,000 | +1.3% | 123,626 | -0.2% | 0.15% | -3.9% |
| Q1 2018 | $2,722,000 | -5.9% | 123,826 | -0.5% | 0.16% | -5.5% |
| Q4 2017 | $2,893,000 | -0.2% | 124,485 | -1.4% | 0.16% | -6.8% |
| Q3 2017 | $2,898,000 | +4.0% | 126,240 | 0.0% | 0.18% | -2.2% |
| Q2 2017 | $2,787,000 | -3.2% | 126,240 | 0.0% | 0.18% | -7.2% |
| Q1 2017 | $2,880,000 | +8.8% | 126,240 | -0.2% | 0.19% | +1.0% |
| Q4 2016 | $2,646,000 | -20.8% | 126,481 | +0.0% | 0.19% | -23.8% |
| Q3 2016 | $3,343,000 | -4.6% | 126,480 | -0.0% | 0.25% | -6.7% |
| Q2 2016 | $3,506,000 | – | 126,540 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |